CLINICAL_TRIALS
research
· 2025-12-22
Clinical Trial Update: Harmony TPV EMEA PMS [NA]
Summary
This update indicates that recruiting is ongoing for the Harmony TPV in the EMEA region under post-market surveillance for severe pulmonary valve regurgitation.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medtronic Cardiovascular | Conditions: Severe Pulmonary Valve Regurgitation | NA | Status: RECRUITING